Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001658021-22-000002
Filing Date
2022-12-22
Accepted
2022-12-22 14:14:10
Documents
1
Effectiveness Date
2022-12-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8457
  Complete submission text file 0001658021-22-000002.txt   9513
Mailing Address 67 SOUTH BEDFORD STREET, SUITE 400W BURLINGTON MA 01803
Business Address 67 SOUTH BEDFORD STREET, SUITE 400W BURLINGTON MA 01803 617-468-4646
General Oncology, Inc. (Filer) CIK: 0001658021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-343809 | Film No.: 221481514